Logo image of IVF

INVO FERTILITY INC (IVF) Stock Analyst Earnings Estimates

NASDAQ:IVF - Nasdaq - US44984F6097 - Common Stock - Currency: USD

1.78  -0.03 (-1.66%)

After market: 1.77 -0.01 (-0.56%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
IVF revenue by date.IVF revenue by date.
820K
-80.29%
3.021M
268.37%
6.532M
116.25%
7.051M
7.95%
7.756M
10.00%
8.531M
9.99%
93.979M
1,001.62%
125.48M
33.52%
155.47M
23.90%
EBITDA
YoY % growth
IVF ebitda by date.IVF ebitda by date.
-10.55M
-103.28%
-6.566M
37.76%
-6.694M
-1.95%
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
IVF ebit by date.IVF ebit by date.
-10.63M
-103.64%
-6.767M
36.34%
-7.614M
-12.51%
-14.206M
-86.58%
-25.55M
-79.86%
-49.286M
-92.90%
30.351M
161.58%
49.166M
61.99%
66.857M
35.98%
Operating Margin
IVF operating margin by date.IVF operating margin by date.
-1,296.34%-224.03%-116.56%-201.47%-329.42%-577.73%32.30%39.18%43.00%
EPS
YoY % growth
IVF eps by date.IVF eps by date.
-213.60
-32.44%
N/A
99.81%
N/A
-3,775.00%
-1.12
92.84%
-0.99
11.71%
-1.86
-87.76%
N/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth
-0.06-0.04-0.05
99.93%
Revenue
Q2Q % growth
1.692M
-7.87%
1.833M
27.90%
1.904M
-62.66%
EBITDA
Q2Q % growth
N/AN/AN/A
EBIT
Q2Q % growth
-3.41M
-79.19%
-3.694M
-184.03%
-3.836M
-10.74%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2024
Q2Q % growth
-77.61 -10.61-67.01-631.82%
Q3 2023
Q2Q % growth
-0.70
98.61%
%
Q2 2023
Q2Q % growth
-3.06
94.46%
%
Q1 2023
Q2Q % growth
-0.20
99.62%
%
Q4 2022
Q2Q % growth
-55.20
-1,816.67%
-46.06-9.14-19.85%
Q3 2022
Q2Q % growth
-50.40
12.50%
-31.51-18.89-59.94%
Q2 2022
Q2Q % growth
-55.20
-35.29%
-58.182.985.12%
Q1 2022
Q2Q % growth
-52.80
12.00%
-60.607.8012.87%
Q4 2021
Q2Q % growth
-2.88
98.00%
-54.5451.6694.72%
Q3 2021
Q2Q % growth
-57.60 -48.48-9.12-18.81%
Q2 2021
Q2Q % growth
-40.80 -46.065.2611.41%
Q1 2021
Q2Q % growth
-60.00 -42.42-17.58-41.44%
Q4 2020
Q2Q % growth
-144.00 -52.12-91.88-176.31%
IVF Yearly EPS VS EstimatesIVF Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 -50 -100 -150 -200
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q1 2025
Q2Q % growth
1.637M
3.86%
1.622M15.2K0.94%
Q4 2024
Q2Q % growth
5.099M
269.01%
1.515M3.584M236.57%
Q3 2024
Q2Q % growth
1.433M
47.75%
%
Q2 2024
Q2Q % growth
1.837M
473.94%
%
Q1 2024
Q2Q % growth
1.576M
350.37%
%
Q4 2023
Q2Q % growth
1.382M
393.50%
%
Q3 2023
Q2Q % growth
970K
304.17%
%
Q2 2023
Q2Q % growth
320K
113.33%
%
Q1 2023
Q2Q % growth
350K
118.75%
%
Q4 2022
Q2Q % growth
280K
-90.82%
259.57K20.43K7.87%
Q3 2022
Q2Q % growth
240K
9.09%
505K-265K-52.48%
Q2 2022
Q2Q % growth
150K
-28.57%
334.815K-184.815K-55.20%
Q1 2022
Q2Q % growth
160K
-76.47%
246.44K-86.44K-35.08%
Q4 2021
Q2Q % growth
3.05M
1,425.00%
211.767K2.838M1,340.26%
Q3 2021
Q2Q % growth
220K
-35.29%
328.755K-108.755K-33.08%
Q2 2021
Q2Q % growth
210K
-16.00%
413.595K-203.595K-49.23%
Q1 2021
Q2Q % growth
680K
161.54%
598.93K81.07K13.54%
Q4 2020
Q2Q % growth
200K
-39.39%
445.41K-245.41K-55.10%
Q3 2020
Q2Q % growth
340K
13.33%
%
Q2 2020
Q2Q % growth
250K
-62.12%
%
Q1 2020
Q2Q % growth
260K
36.84%
%
IVF Yearly Revenue VS EstimatesIVF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M 150M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% N/A 0% N/A
Revenue0% N/A 0% N/A